TYP
Click for more information
10.5% 2.1¢ tryptamine therapeutics limited

Interesting seeing Victoria is now "home" of the mRNA technology...

  1. mining=$
    1,087 Posts.
    lightbulb Created with Sketch. 500
    clock Created with Sketch.
    14/12/21
    11:38
    Post #: 58278487
    Interesting seeing Victoria is now "home" of the mRNA technology in Australia and could become a world leader in producing mRNA vaccines. This is great news for exopharm should exosomes become the way of delivering mRNA in the future (which is what we believe given the investment in this stock). One for the bottom drawer but one I am holding with excitement albeit a horrible share price decline.

    imo dyor gltah
    EX1 Price at posting: 40.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
ABY Adore Beauty buys up wellness brand iKOU for $25M cash
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.002(10.5%) 		Mkt cap ! $22.87M
Open High Low Value Volume
1.9¢ 2.1¢ 1.9¢ $27.87K 1.464M

Buyers (Bids)

No. Vol. Price($)
2 527780 1.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 613000 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.